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Abstract
Mammalian AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that acts as
a sensor of cellular energy status. AMPK is a heterotrimer of three different subunits, i.e. α, β and
γ, with α being the catalytic subunit and β and γ having regulatory roles. Although several studies
have defined different domains in α and β involved in the interaction with the other subunits of the
complex, little is known about the regions of the γ subunits involved in these interactions. To study
this, we have made sequential deletions from the N-termini of the γ subunit isoforms and studied the
interactions with α and β subunits, both by two hybrid analysis and by co-immunoprecipitation. Our
results suggest that a conserved region of 20-25 amino acids in γ1, γ2 and γ3, immediately N-terminal
to the Bateman domains, is required for the formation of a functional, active αβγ complex. This region
is required for the interaction with the β subunits. The interaction between the α and γ subunits does
not require this region and occurs instead within the Bateman domains of the γ subunit, although the
α-γ interaction does appear to stabilize the β-γ interaction. In addition, sequential deletions from the
C-termini of the γ subunits indicate that deletion of any of the CBS motifs prevents the formation of
a functional complex with the α and β subunits.
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INTRODUCTION
Mammalian AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that
acts as a sensor of cellular energy status. It is activated by cellular stresses that deplete ATP,
either by inhibiting ATP production (e.g. hypoxia, glucose deprivation, heat shock,
mitochondrial inhibitors) or by accelerating ATP consumption (e.g. muscle contraction).
Depletion of ATP is always accompanied by increases in AMP due to the reaction catalyzed
by adenylate kinase, and the increase in AMP:ATP ratio activates AMPK in an ultrasensitive
manner (1). Once activated it switches on catabolic pathways and switches off many ATP-
consuming processes including anabolic pathways [see (2-5), for reviews]. AMPK is a
heterotrimer comprised of three different subunits, i.e. α, β and γ. The α subunit is the catalytic
subunit; it contains a highly conserved kinase domain at the N-terminus and a less well-
conserved C-terminal regulatory domain. Two isoforms have been described, i.e. α1 and α2;
both are localized in the cytoplasm although α2 is also present in the nucleus (6). The γ subunits
contain four tandem repeats of a structural module called a CBS motif (7), named after the
enzyme cystathionine β-synthase, in which a pair of CBS motifs form a domain that binds the
allosteric activator S-adenosyl methionine (8). In the AMPK γ subunits the four CBS motifs
are now known to act in two pairs, forming two domains (referred to as Bateman domains) that
bind the regulatory nucleotides, AMP and ATP, in a mutually exclusive manner (8). Three
isoforms of the γ subunit, i.e. γ1, γ2 and γ3, are encoded by distinct genes; they have poorly
conserved N-terminal regions that in γ2 and γ3 are subject to alternate splicing, whereas the
C-terminal regions, containing the two tandem Bateman domains, are conserved in all three
isoforms. Two isoforms of the β subunit (β1 and β2) have been described; they differ at their
N-termini but both appear to interact with the α and γ subunits with similar efficiency (9-10).
The β subunits have two conserved regions, a central glycogen-binding domain (11-13) and a
C-terminal domain that is the only region required for the formation of the complex with α and
γ (11).
All three subunits are required to form a functional AMPK complex (14-15). Recent studies
have begun to delineate the regions of the α and β subunits required for the formation of
heterotrimeric complexes, although there have been some conflicting findings. Detailed
mapping of the C-terminal domain of β1 suggested that the last 25 residues are sufficient to
form a complex with γ1, γ2 and γ3, with the C-terminal residue (Ile-270) being essential for
the formation of a β-γ complex in the absence of α (16). By contrast, it was recently reported
that β2 and γ1 do not form a complex in the absence of α2 (17). The C-terminal domain of the
α subunit has been reported to be involved in the interaction with β (16) and γ subunits (10),
although another study has suggested that γ1 interacts with α2 via both the N-terminal catalytic
domain and the C-terminal domain of the latter (17).
As yet, little is known about which portions of the γ subunits are involved in the interaction
with the α and β subunits. In order to study this, we have made deletions of the regions of the
γ subunits N-terminal to the Bateman domains. Our results show that a conserved sequence of
20-25 residues, immediately N-terminal to the first Bateman domain (the “pre-CBS1
sequence”), is required for the binding of γ1, γ2 and γ3 to the β subunits and for the formation
of an active αβγ complex. In addition, we have made C-terminal deletions of the γ subunits
and observed that deletion of any of the CBS motifs prevents the formation of functional
complexes with the α and β subunits.
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MATERIALS AND METHODS
1.- Microorganisms, culture conditions and genetic methods
Escherichia coli DH5α was used as the host strain for plasmid constructions. It was grown in
LB (1% peptone, 0.5% yeast extract, 1% NaCl, pH 7.5) medium supplemented with 50 mg/L
ampicillin.
Saccharomyces cerevisiae CTY10-5d (MATa ade2 his3 leu2 trp1 gal4 gal80 URA3::lexAop-
lacZ) was used in the two-hybrid experiments. When indicated, the yeast strains FY250 and
FY250 snf1Δ, containing the pSH18-18 reporter plasmid (18) were also used in two-hybrid
experiments. Yeast transformation was carried out using the lithium acetate protocol (19).
Yeast cultures were grown in synthetic complete (SC) medium lacking the corresponding
supplements to maintain selection for plasmids (20).
2.- Oligonucleotides
Oligonucleotides used in this work are described in Table I
3.- Plasmids
Plasmid pEG-AMPKγ3 (expressing LexA-AMPKγ3 fusion protein) was obtained by
subcloning an EcoRI/XhoI fragment from plasmid pcDNA3-AMPKγ3 (containing the human
cDNA of AMPKγ3) into plasmid pEG202 (21) digested with EcoRI/XhoI. Progressive
deletions of the AMPKγ3 ORF were obtained by PCR using the forward oligos Gamma3-A,
B, C, D, E, F and the reverse oligo Gamma3-SalI (Table I). The amplified fragments were
sequenced to check the absence of undesired modifications and then, digested with EcoRI/SalI
and subcloned into pEG202 to obtain plasmids pEG-AMPKγ3A, B, C, D, E and F, respectively.
To construct plasmids pEG-AMPKγ1 (LexA-AMPKγ1) and pACT2-AMPKγ1, a 1.9 kb ApaI/
NotI fragment from plasmid pcDNA3-AMPKγ1 (containing the human cDNA of AMPKγ1),
was blunted with Klenow enzyme and ligated into the SmaI site of pEG202 and pACT2 (22),
respectively. Plasmid pEG-AMPKγ1-NtΔ was obtained by amplifying the corresponding
fragment by PCR using oligos Gamma1-CBS1 and Gamma1-2 (Table I). The fragment was
then digested with SmaI/XhoI and subcloned into pEG202, previously digested with SmaI/
XhoI. To obtain plasmid pACT2-AMPKγ1-CBS1, a BglII fragment from pACT2-AMPKγ1
(containing the N-terminal domain and the first CBS motif) was subcloned into pACT2
digested with BglII and treated with alkaline phosphatase. Plasmid pACT2-AMPKγ1-CBS12
was obtained eliminating an EcoRI fragment from pACT2-AMPKγ1 and religating. Plasmid
pACT2-AMPKγ1-CBS123 was obtained by amplifying the corresponding fragment by PCR
using oligos Gamma1-1 and Gamma1-CBS123 (Table I). The fragment was then digested with
NotI, filled with Klenow enzyme, digested with XhoI and then subcloned into pACT2 digested
with SmaI and XhoI.
To construct plasmid pEG-AMPKγ2 (LexA-AMPKγ2), an EcoRI/XhoI fragment from plasmid
pcDNA3-AMPKγ2 (containing the human cDNA of AMPKγ2) was subcloned into plasmid
pEG202 (21) digested with EcoRI/XhoI. Plasmid pEG-AMPKγ2 short (LexA-AMPKγ2 short)
was constructed in a similar way from plasmid pcDNA3-AMPKγ2 short (expressing γ2 from
residue 242 up to 569). Plasmid pEG-AMPKγ2-NtΔ was obtained by amplifying the
corresponding fragment by PCR using oligos Gamma2-CBS1 and Gamma2-2 (Table I). The
fragment was then digested with SmaI/XhoI and subcloned into pEG202, previously digested
with SmaI/XhoI. To obtain yeast plasmids expressing different mutated forms of AMPKγ2,
EcoRI/XhoI fragments from plasmids pcDNA3-AMPKγ2 R302Q, L-ins, H383R and T400N
(containing the human cDNA of the corresponding mutated forms) were subcloned into
pEG202.
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To express the “short” and “long” truncations of γ subunits for co-precipitation studies in
mammalian cells, DNAs encoding residues 22-331 (γ1L) or 47-331 (γ1S) of human γ1
(P54619), 253-569 (γ2L) or 279-569 (γ2S) of human γ2 (Q9UGJ0), or 177-489 (γ3L) or 202-489
(γ3S) of human γ3 (Q9UGI9) were cloned by RT-PCR from human brain mRNA (γ1, γ2) or
by PCR from IMAGE clone 40005880 (γ3), and subcloned using EcoRI and KpnI sites into
pFLAG-CMV5a (Sigma). The expressed proteins have a single methionine before the residues
listed and a FLAG tag at the C-terminus.
Other plasmids used in this study were pACT2 (22), pACT2-AMPKα2 (GAD-AMPKα2),
pACT2-AMPKβ2 (GAD-AMPKβ2), pBTM-AMPKα2 (LexA-AMPKα2) and pBTM-
AMPKβ2 (LexA-AMPKβ2) (10).
4.- Antibodies
The antibodies used in this study were as follows: sheep polyclonal anti-panβ (23), sheep
polyclonal anti-α1 and anti-α2 (14), mouse monoclonal anti-myc (Sigma), mouse monoclonal
anti-FLAG (Sigma).
5.-β-Galactosidase assays
β-galactosidase activity was measured in yeast permeabilized cells and expressed in Miller
units as described in Ludin and collaborators (24).
6.- Preparation of yeast cell extracts and immunoblot analysis
Yeast cells corresponding to 1 Unit A600 were collected by rapid centrifugation (14.000 rpm,
1 min), resuspended in 100 μl of Laemmli sample buffer and boiled for 3 min. Glass beads
(0.3 g, 450 μm diameter) were added to the suspension and then cells were vortexed at full
speed for 30 sec. The suspension was boiled again for 3 min and centrifuged at 14.000 rpm for
1 min. 20 μl of the supernatants were subjected to sodium dodecyl sulphate polyacrylamide
gel electrophoresis and immunoblotting using anti-LexA polyclonal antibodies (Invitrogen) or
anti-HA polyclonal antibodies (Clontech).
7.- Cell culture and transfection
HeLa and HEK293 cells were grown at 37°C in a 5% CO2 incubator. Cells were grown in
Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum. All
transfections were carried out using Superfect transfection reagent (Quiagen) following the
manufactures' instructions.
8.- Co-immunoprecipitation studies
Cells were transiently transfected with combinations of plasmids encoding the α (N-terminal
myc-tagged), β (untagged) and γ (C-terminal FLAG-tagged) subunits of AMPK. Cell lysates
were prepared 24 hr post-transfection and incubated with anti-FLAG M2-agarose (Sigma) for
2 hr on a rotating wheel at 4°C. Beads were washed three times in lysis buffer (50 mM Tris-
HCl, pH 7.3 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 1 mM Na pyrophosphate, 0.1% (v/v)
Triton X-100, 1 mM dithiothreitol, 0.1 mM phenylmethane sulfonylfluoride (PMSF), 0.1 mM
benzamidine, 1 μg/ml soybean trypsin inhibitor). Samples were resolved by SDS-PAGE on a
4-12% gradient NuPAGE gel, using MOPS running buffer (Invitrogen). Western blots were
carried out and protein detected by antibody labelling and enhanced chemiluminescence using
standard techniques.
9.- Kinase assays
Activity of AMPK in immunoprecipitates was measured as described previously (25).
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10.- Production and growth of mouse embryo fibroblasts
AMPKα subunit knockouts MEFs (α1 −/−; α2 −/−) and wild type controls were constructed
and grown as described previously (26). They were transfected using lipofectamine
(Invitrogen) according to manufacturer's instructions.
RESULTS
The γ subunits interact with α and β via their N-terminal regions by two-hybrid analysis
We commenced our study by analyzing two hybrid interactions of mammalian AMPK subunits
expressed in yeast. Since the α2β2γ3 complex appears to play an important role in skeletal
muscle (27), we initially studied the interaction between β2 and γ3, which has an N-terminal
extension of 201 amino acids prior to the first Bateman domain. A LexA-γ3 fusion protein
interacted strongly with a GAD-β2 fusion (Fig. 1), so we made sequential deletions from the
N-terminus of γ3 and checked their interaction with GAD-β2. As shown in Fig. 1B, deletion
of the first 33 amino acids of γ3 (γ3A) decreased the interaction slightly, while further
successive deletions of 45 (γ3B) and 40 (γ3C) amino acids did not further modify the
interaction. However, the deletion of the following 35 amino acids (γ3D) reduced the
interaction and the deletion of the next 47 amino acids (γ3E; truncated at the start of the first
Bateman domain) completely abolished it. Additional deletion of the first CBS motif (γ3F)
gave the same negative results as γ3E. Control experiments using the various LexA-γ3
constructs and the empty vector pACT2 gave negligible (<1 unit) β-galactosidase activity in
all the cases (not shown). Western blot analysis indicated that all deleted forms were expressed
at similar levels (Fig. 1C). These results suggested that the interaction between γ3 and β2
requires the 47 amino acids immediately prior to the first Bateman domain, although residues
N-terminal to that may improve the interaction. We also attempted to study the interaction
between γ3 and α2 using the same approach, but there was a very low level of interaction
evident even with the full length construct (<1 unit of β-galactosidase).
We next studied γ1, the most abundant γ subunit in skeletal muscle (27). As shown in Fig. 2A,
a fusion between LexA and full-length γ1 was able to interact strongly with both α2 and β2.
However, the deletion of the first 41 amino acids from the N-terminus (a truncation at the start
of the first Bateman domain) completely abolished the interaction with both α2 and β2. Control
experiments using both LexA-γ1 constructs and the empty vector pACT2 gave negligible (<1
unit) β-galactosidase activity (not shown). Western blot analysis indicated that the truncated
LexA-γ1 protein was produced at similar levels to the full length protein (Fig. 2A, right panel).
Similar results were obtained when we studied γ2. A fusion between LexA and full-length γ2,
containing an N-terminal extension of 278 amino acids prior to the first Bateman domain,
interacted with α2 and β2 (Fig. 2B). A truncated form containing only the first 37 amino acids
prior to the first Bateman domain interacted strongly with α2 and β2 (Fig. 2B), perhaps because
the truncated form was better expressed (see Fig. 2B, right panel). However, the deletion of
these 37 amino acids from the N-terminus (a truncation at the start of the first Bateman domain)
completely abolished the interaction with both α2 and β2 (Fig. 2B). Control experiments using
the different LexA-γ2 constructs and the empty vector pACT2 gave negligible (<1 unit) β-
galactosidase activity (not shown). Therefore, our results suggest that 37-47 amino acids
immediately prior to the first Bateman domain of the three γ subunits are necessary for their
interaction with α2 and β2.
Since yeast contains orthologues to the three AMPK subunits (AMPKα, Snf1; AMPKβ, Gal83/
Sip1/Sip2; AMPKγ, Snf4), we studied whether the interaction between AMPKβ and the three
γ subunits was dependent on the presence of the orthologous Snf1/AMPKα subunit. With this
aim, we repeated the two-hybrid experiments in yeast cells lacking the SNF1 gene (snf1Δ
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mutant). As shown in Fig. 2C, the three γ subunits interacted with the β2 subunit in the absence
of Snf1/AMPKα. These results indicated that the β and the γ subunits interacted directly. The
lower levels of interaction observed in snf1Δ mutants may suggest that the presence of the α
subunit stabilizes the β-γ interaction.
Mutations in the γ2 Bateman domains do not affect binding to α2 and β2
Mutations in the PRKAG2 gene, encoding the γ2 subunit, cause heart diseases of varying
degrees of severity, that appears to be caused by excessive glycogen storage (28-29). Several
mutations have been described, e.g. R302Q (30), L-insert (an insertion of an extra Leu residue
between the conserved Arg350-Glu351) and H383R (31), T400N and N488I (28), R531G
(32) and R531Q (33). In all cases, the described mutations affect critical residues in different
CBS motifs of the γ2 subunit and, with the possible exception of the L-insert mutation, produce
proteins with deficient AMP binding capacity (8,33). We studied four of these mutations
(R302Q, L-insert, H383R and T400N; Fig. 3A) and checked by two-hybrid analysis whether
the mutated forms interacted properly with α2 and β2. Compared with the wild type, all of the
mutants interacted normally with α2 and the interaction was increased in the absence of glucose,
as reported previously for the wild type (10) (Fig. 3B). None of the mutations affected the two-
hybrid interaction of γ2 with β2 either (Fig. 3C).
Alignment of γ subunit sequences
We next aligned the sequences of human γ1, γ2 and γ3 with those of the orthologues from
Drosophila melanogaster, Disctyostelium discoideum, Saccharomyces cerevisiae (Snf4) and
Schizosaccharomyces pombe (Fig. 4). According to the UNIPROT database, the first Bateman
domains of γ1, γ2 and γ3 begin at Lys-42, Lys-279 and Lys-202 respectively. In a recent study,
we expressed in bacteria constructs of γ1, γ2 and γ3 that commenced near this point and showed
that they bound two molecules of AMP or ATP with the expected affinities (8). Thus, upstream
residues are not required for binding of the regulatory nucleotides. However, the alignment in
Fig. 4 shows that there is a stretch of about 25 amino acids (which we shall call the “pre-CBS1
sequence”) prior to the first Bateman domain that is well conserved across the three human γ
isoforms and the four distantly related eukaryotic species. There is a conserved pattern of
hydrophobic residues, while Phe, Tyr and Asp residues at positions 12, 19 and 20, and a basic
residue at position 16 (His, Lys or Arg) are completely conserved.
Requirement for the pre-CBS1 sequence revealed by co-precipitation
In order to test the importance of this “pre-CBS1 sequence” for complex formation and also
to map the interactions using a method different from two hybrid analysis, we made constructs
of human γ1, γ2 and γ3 that were either truncated at the start of the first Bateman domain
(γ1S, γ2S, γ3S; S: “short”) or that contained the 25-26 residue pre-CBS1 sequence shown in
Fig. 4 (γ1L, γ2L, γ3L; L: “long”). These were co-expressed in HeLa cells with β1 and myc-
tagged α1, and the γ subunits immunoprecipitated with anti-FLAG antibody, making use of
the FLAG tag at the C-termini of all γ variants. Fig. 5A shows the results of Western blotting
using anti-myc and anti-FLAG antibodies to detect the α and γ subunits, respectively. A
consistent finding was that myc-α1 (detected using anti-myc antibody) only co-precipitated
with γ1, γ2 and γ3 when the latter contained the pre-CBS1 sequence (compare lane 1 (L
variants) with lane 5 (S variants) for each γ subunit in the anti-myc blot). Unfortunately, the
γ1S variant appeared to be expressed at a much lower level than the γ1L variant. Also, for
reasons that are unclear, it always migrated as a doublet, with one band migrating faster than
γ1L as expected, but the other migrating more slowly. Nevertheless, the myc-tagged α1 subunit
(which was expressed equally well in both cases) only co-precipitated significantly with the
γ1L variant (Fig. 5A, upper panels). Expression of the γ2-FLAG fusions was low using either
the long or short variant. Despite this, there was evidence that myc-α1 only co-precipitated
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with γ2L and not with γ2S (Fig. 5A, middle panels). The results were most clear-cut with the
γ3 variants (Fig. 5A, lower panels). The γ3-FLAG and myc-α1 fusions expressed equally well
irrespective of the presence or absence of the pre-CBS1 sequence on γ3, but myc-α1 only co-
precipitated significantly with γ3L and not with γ3S.
Very similar results were obtained when the constructs were expressed in HEK293 rather than
HeLa cells (not shown). We also expressed myc-α1, β1 and the γ-FLAG variants in both HeLa
and HEK293 cells, immunoprecipitated the corresponding AMPK complexes using anti-myc
or anti-FLAG antibodies, and measured AMPK activity. Fig. 5B shows that active complexes
were only obtained in anti-myc immunoprecipitates from HEK293 cells using the long variants
(γ1L. γ2L, γ3L). The rather low level of activity obtained with γ2L was consistent with the
generally low level of expression obtained using this construct compared with γ1L or γ3L (Fig.
5A). When the short variants (γ1S, γ2S, γ3S) were expressed instead, the activities obtained
were not significantly different from the background level in untransfected cells. Similar results
were obtained by immunoprecipitation using anti-FLAG antibodies (not shown).
To confirm that AMPK complexes containing the pre-CBS1 sequence were regulated normally
in intact cells, we also treated HEK293 cells expressing myc-α1, β1 and γ1L- or γ1S-FLAG
with 10 mM deoxyglucose. Fig. 5C shows that the γ1L-FLAG complex was activated by
deoxyglucose as expected, whereas only background levels of activity were observed in the
untransfected cells or cells expressing γ1S-FLAG, with or without deoxyglucose.
The pre-CBS1 sequence of γ interacts with the β subunit
To test whether the pre-CBS1 sequence interacts with the α or the β subunits, we co-expressed
the γ1S, γ1L, γ2S, γ2L, γ3S or γ3L constructs in HeLa cells together with plasmids encoding
either myc-α1, myc-α2, β1 or β2 alone, i.e. without DNA encoding the third subunit. Cell
lysates were immunoprecipitated with anti-FLAG and the respective α or β subunit detected
in the immunoprecipitates with the corresponding antibodies. The experiments with β1 or β2
(detected using a pan-β antibody) showed that both isoforms were able to form a complex with
γ1L or γ3L, but not with γ1S or γ3S (Fig. 6A). We also attempted the experiment with the γ2
constructs but, probably because of the low level of expression any complex formed with
γ2L was not detectable (not shown). On the other hand, myc-α1 or myc-α2 appeared to form
complexes with γ1 and γ3 variants, irrespective of the presence or absence of the pre-CBS1
sequence (Fig. 6B). These results suggest that, while the interaction between the β and γ
subunits requires the pre-CBS1 sequence, α1 or α2 interact with γ subunits independently of
this sequence, i.e. via the Bateman domains. Surprisingly, this is different from the results
obtained in experiments when a β subunit is also expressed (e.g. Fig. 5A, 6C), where the
association of α and γ is dependent on the presence of the pre-CBS1 sequence.
Recently, it has been proposed that the β and γ subunits of AMPK do not interact directly, but
only indirectly via the α subunit (17). The results in Fig. 6A argue against that model, but a
caveat was that HeLa cells do express low levels of endogenous α subunits. To rule out the
possibility that endogenous α subunits could be providing a bridge between the over-expressed
β and γ subunits, we co-expressed the γ-FLAG variants and β1, with or without myc-α1, in
wild type or double knockout [α1(−/−); α2(−/−)] mouse embryo fibroblasts (WT or KO MEFs).
Unfortunately, the MEF cell lysates contain an abundant protein that migrates just behind the
α subunits on SDS-PAGE. This protein binds the anti-α1/α2 antibody and/or the second
antibody used, and therefore almost obscures the α subunits when cell lysates were analyzed
by Western blotting. However, this protein was not present in the immunoprecipitates.
Endogenous α subunits from WT MEF cells could be seen to co-precipitate with γ1L (lane 8
in Fig. 6C) but no signal was obtained in the equivalent samples from KO MEFs (lane 8 in Fig.
6D), confirming the complete absence of α subunits from KO cells. Recombinant myc-α1 was
also observed to co-precipitate with γ1L when myc-α1 was expressed in either WT or KO MEFs
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(lane 4 in Fig. 6C and 6D). Despite the complication of the abundant protein in the MEF cell
lysates, the results clearly show that β1 interacts with γ1L but not with γ1S, even in KO MEFs
that completely lack both α subunits (anti pan-β blot, lane 8, Fig. 6C and 6D). The presence of
endogenous α1 in WT MEFs, or over-expressed myc-α1 in either WT or KO MEFs does,
however, appear to markedly increase the amount of β1 that co-immunoprecipitates with γ1L
but not with γ1S. These observations suggest that the α subunit does stabilize β-γ interaction,
although it is not essential for the interaction to occur.
Both Bateman domains of the γ subunits are also necessary to allow the formation of a
heterotrimeric complex
We also made sequential deletions from the C-terminus of γ1 and found that upon elimination
of the last CBS motif of the second Bateman domain, the two-hybrid interactions with α2 and
β2 were completely lost (Fig. 7). Successive deletions of the remaining CBS motifs gave the
same negative results. Control experiments using LexA-α2 or LexA-β2 and the empty vector
pACT2 gave negligible (<1 unit) β-galactosidase activity (not shown). Western blot analysis
indicated that the truncated GAD-γ1 proteins were produced at similar levels (Fig. 7, right
panel).
We also made various truncations of human γ2 that contained only CBS motifs 3-4 (Bateman
domain 2) or 2-4 (half Bateman domain 1 plus Bateman domain domain 2), as well as one that
commenced at residue 244 (thus containing the pre-CBS1 sequence) but was truncated at the
end of the first Bateman domain and did not contain the second domain. None of these
constructs formed functional AMPK complexes when co-expressed with α1 and β1 (data not
shown). These results indicated that the two Bateman domains may fold into a combined
structure necessary to allow the formation of an active heterotrimeric complex. If this structure
is altered, e.g. by deleting one of the CBS motifs, then the formation of a functional
heterotrimeric complex is prevented.
DISCUSSION
AMPK exists as heterotrimeric complexes, and all three subunits are required to form a
functional, AMP-activated complex when the full-length subunits are expressed (14-15). Since
the crystal structure of the complex has not been determined yet, alternative methods have been
used to obtain information about its architecture. For example, co-expression and co-
immunoprecipitation techniques have been used to show that only the C-terminal domain of
β is required to form a functional complex with α and γ (11), while additional C-terminal
truncations have been used to more precisely map the regions of the C-terminal domain of β1
required for binding to α (residues 186-270) and γ (residues 246-270) (16). The same technique
was used to show that a C-terminal region of α1 lacking the last 75 residues (313-473) was all
that was required for binding to β1 (16). Two-hybrid analysis has also been used as an
alternative technique to analyze the interactions among the three different subunits (34-35).
Recently, we reported that only the C-terminal domain of α2 (residues 313-552) was required
for the interaction with γ1 (10). The two-hybrid technique has also been used extensively to
study the architecture of the yeast orthologue of mammalian AMPK, i.e. the SNF1 complex
(36). The results are broadly similar to those obtained in the mammalian system: i) yeast α
subunit (Snf1) interacts via its C-terminal domain with both the γ (Snf4) and β (Gal83/Sip1/
Sip2) subunits (37); (ii) several deletions or point mutations in Snf1 also defined critical
residues in the kinase domain and C-terminal domain involved in the interaction with Snf4
(38); iii) yeast β subunits contain C-terminal domains referred to as the ASC (association with
Snf1 complex) domain reported to be involved in the interaction with Snf4 (γ subunit) and a
central KIS (kinase interacting sequence) domain, which overlaps with the glycogen-binding
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domain of mammalian β subunits, and which is reported to interact with the α subunit (Snf1)
(37,39).
Until now, nothing has been known in either the yeast or the mammalian system about which
part of the γ subunit is involved in the interaction with the α and β. In this study we present
evidence that a conserved region of 20-25 amino acids immediately N-terminal to the first
Bateman domain of mammalian γ subunits is required for binding to the β subunits. Our results
are based on analysis of the interactions using two hybrid analyses of mammalian subunits
expressed in yeast, as well as by co-precipitation and measurement of kinase activity with α,
β and γ subunits co-expressed in mammalian cells. The results obtained with the expression
of truncated forms of γ1, γ2 and γ3 in mammalian cells show that a region of 20-25 amino
acids immediately prior to the first Bateman domain is essential for formation of a functional
αβγ complex (Fig. 5). This sequence is particularly well conserved in a central region of 17
amino acids, which is rather hydrophobic and has the consensus sequence
SXIYMKFMRSHKCYDLI. The sequence contains three residues that are completely
conserved between human γ1, γ2 and γ3 and their orthologues in D. melanogaster, D.
discoideum, S. cerevisiae and S. pombe, i.e. a Phe at position 7 and a Tyr-Asp doublet at position
14-15 (in bold in consensus sequence). There is also a conserved basic residue at position 11,
and hydrophobic residues are conserved at positions 4, 8, 16 and 17 (underlined in consensus
sequence) (Fig. 4). Although our results suggest that this sequence is required for the interaction
between γ and β subunits, at present, we cannot rule out the possibility that the removal of this
sequence causes major conformational changes in the overall structure of the γ subunits that
precludes their interaction with the β subunits.
Additionally, we have also used the two-hybrid method to analyse the interaction with α and
β of several point mutations in γ2 that caused a hereditary heart disease in humans (Wolf-
Parkinsson-White syndrome with cardiac hypertrophy). Our results indicate that the pathogenic
defect associated with these mutations is not due to deficiencies in binding of γ2 to α2 and
β2. This is consistent with findings that these γ2 mutations give rise to complexes that are
active, although in some cases defective in AMP activation, when co-expressed with α and β
subunits in mammalian cells (8,33,40). The findings that these mutant complexes were active
suggested that they contained all three subunits, although this had not been directly addressed
in the previous studies.
Recently, evidence was presented, using a co-precipitation approach, that mouse β2 and γ1
subunits do not interact directly (17). The authors proposed instead that the α subunit bridges
the interaction between β and γ. Our results do not support this model. Firstly, yeast two-hybrid
analysis indicates that the interaction between β and γ subunits occurs in the absence of Snf1/
AMPKα subunit (Fig. 2C). Secondly, both β1 and β2 interacted with γ1 and γ3 when over-
expressed together in HeLa cells without an α subunit, and this was dependent on the pre-CBS1
sequence of the γ subunits because it did not occur with the “short” variants (Fig. 6A). Both
α1 and α2 also interacted with γ1 and γ3 in the absence of a co-expressed β subunit, but this
was not dependent on the pre-CBS1 sequence because the interaction occurred equally well
with the “short” as the “long” γ variants (Fig. 6B). The fact that the β subunits require the pre-
CBS1 sequence to interact with the γ subunits, whereas the α subunits do not, argues against
the idea that α subunits provide a bridge between β and γ. One caveat with our experiments in
HeLa cells is that these cells do express low level of endogenous α subunit. To rule out the
possibility that the endogenous α subunit might bridge the β-γ interaction, we repeated the
experiment in wild type mouse embryo fibroblast (WT MEFs) and double knockout cells that
completely lacked α subunits (KO MEFs). The results clearly showed that a β-γ interaction,
which was dependent on the pre-CBS1 sequence, was still evident in the KO MEFs. However,
the presence of α subunits, either endogenous in the WT MEFs or recombinant myc-α1 subunit
in WT or KO MEFs, did appear to greatly increase the amount of β1 recovered in the γ1-FLAG
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immunoprecipitates (Fig. 6C, 6D). Thus, the presence of an α subunit may stabilize the β-γ
interaction. The lower levels of interaction observed between β and γ in snf1Δ mutants are also
consistent with this hypothesis.
Some rather surprising findings were that when α and γ subunits were expressed on their own,
they interacted even in the absence of the pre-CBS1 sequence (Fig. 6B), but when they were
co-expressed with a β subunit, co-precipitation with the γ subunits was now dependent on the
presence of the pre-CBS1 sequence on γ (Fig. 5A, 6C). Our interpretation of these somewhat
puzzling findings is that the α and β subunits may form a dimeric complex that interacts
differently with the γ subunits than when the α subunit is present on its own.
We have also made sequential deletions from the C-terminus of γ1 and found that upon
elimination of even one of the four CBS motifs, the two-hybrid interactions with α2 and β2
were completely lost. In agreement with this observation, we also found that a C-terminal
deletion of γ2 (lacking the second Bateman domain) was unable to form an active heterotrimeric
complex. One plausible interpretation of these results is that both Bateman domains are
required to form a functionally combined structure. If one of the CBS motifs or Bateman
domains is deleted, then the structure does not fold properly, leading to an altered conformation
of the protein that cannot bind to α and β even though the pre-CBS1 sequence is present.
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NOTE ADDED IN PROOF
At the time that this manuscript was under revision, Townley and Shapiro (2007,
Sciencexpress, 8 February) have defined the crystal structure of the AMPK complex from the
yeast Schizosaccharomyces pombe. They demonstrate that the γ and β subunits interact directly
and that the pre-CBS1 sequence of the γ subunit participates in the binding to the β subunit.
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Fig. 1.
AMPKγ3 interacts with AMPKβ2 through its N-terminal region. A) Diagram of the deletions
constructed. Deletions were made as described in Materials and Methods and fused in frame
to LexA. The box drawn with a dashed line indicates the region in AMPKγ3 involved in the
interaction. B) Two hybrid analysis of the AMPKγ3-AMPKβ2 interaction. Yeast CTY10.5d
strain was transformed with plasmids expressing GAD-AMPKβ2 and different truncated forms
of LexA-AMPKγ3. Transformants growing exponentially in SC-4% glucose medium were
harvested and the β-galactosidase activity measured. Values correspond to means from four to
six different transformants (bars indicate standard deviation). C) Western blot analysis. Crude
extracts from the transformants described in section B) were analysed by western blot using
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anti-LexA polyclonal antibodies. One representative transformant from each interaction is
shown.
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Fig. 2.
Requirements for the interaction between γ and β subunits using two-hybrid analysis. Yeast
CTY10.5d strain was transformed with plasmids expressing GAD-AMPKα2 or GAD-
AMPKβ2 and either LexA-AMPKγ1 (wild type and N-terminal deleted form, Nt-Δ) (A) or
LexA-AMPKγ2 (full length, short form and N-terminal deleted form, Nt-Δ) (B). Transformants
growing exponentially in SC-4% glucose medium were harvested and the β-galactosidase
activity measured. Values correspond to means from four to six different transformants
(standard deviation lower than 15% in all cases; not shown). Crude extracts from these
transformants were analysed by western blot using anti-LexA polyclonal antibodies. One
representative transformant from each interaction is shown. (C) Interaction between γ and β
in snf1Δ mutants. FY250 (wild type) and FY250 snf1Δ mutant strains containing the pSH18-18
reporter plasmid were transformed with plasmids expressing GAD-AMPKβ2 and either LexA-
AMPKγ1, LexA-AMPKγ2 or LexA-AMPKγ3-D. Transformants growing exponentially in
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SC-4% glucose medium were analyzed as above. Bars indicated standard deviation. Crude
extracts from these transformants were analysed by western blot using anti-LexA polyclonal
antibodies. One representative transformant from each interaction is shown.
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Fig. 3.
Analysis of the interaction of different mutated forms of AMPKγ2 and AMPKα2 and
AMPKβ2. A) Diagram of the position of the different AMPKγ2 mutations used in this study.
B) Interaction with AMPKα2. Yeast CTY10.5d strain was transformed with plasmids
expressing the indicated mutated forms of AMPKγ2 (LexA-AMPKγ2) and GAD-AMPKα2.
Transformants growing exponentially in SC-4% glucose medium were washed with water and
shifted to SC-0.05% glucose medium for three hours. Then samples were harvested from the
cultures grown at high and low glucose conditions and the β-galactosidase activity measured.
Values correspond to means from four to six different transformants (bars indicate standard
deviation). C) Interaction with AMPKβ2. Transformants growing exponentially in SC-4%
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glucose medium were harvested and the β-galactosidase activity measured. Values correspond
to means from four to six different transformants (bars indicate standard deviation).
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Fig. 4.
Alignment of the sequences of portions of the γ subunits from Homo sapiens (γ1 (P54619), γ2
(Q9UGJ0) and γ3 (Q9UGI9)), Drosophila melanogaster (AAC95306), Distyostelium
discoideum (Q559K2), Saccharomyces cerevisiae (P12904) and Schizosaccharomyces
pombe (S67444). Sequences were aligned using AlignX (Vector NTI) and portions of the
alignment are shown (γ1, residues 20-68; γ2, 251-300; γ3, 175-223; D. melanogaster, 162-210;
D. discoideum, 257-305; S. cerevisiae, 12-61; Schiz. pombe, 5-54). The start of the first CBS
motif (first Bateman domain) is shown in bold. Residues that are identical upstream of the first
CBS motif are shown in bold; conservative replacements are underlined.
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Fig. 5.
(A) Co-precipitation of myc-α1 with γ-FLAG constructs when co-expressed with β1 in HeLa
cells; (B) AMPK activity in anti-myc immunoprecipitates when myc-α1 and β1 were co-
expressed with γ-FLAG constructs in HEK293 cells; (C) as (B) but showing the effect of
treatment of cells with deoxyglucose on the activity of the γ1-FLAG constructs. In (A),
plasmids encoding myc-α1 and β1 were co-expressed in HeLa cells with γ-FLAG fusions from
γ1, γ2 or γ3 that either contained (γ1L, γ2L, γ3L) or did not contain (γ1S, γ2S, γ3S) the pre-
CBS1 sequence. Cell lysates were immunoprecipitated with anti-FLAG and lysates and
immunoprecipitates from transfected cells and untransfected controls (-) were analyzed by
Western blotting using anti-myc to detect recombinant α and anti-FLAG to detect recombinant
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γ. In (B), plasmids encoding myc-α1 and β1 were co-expressed in HEK293 cells with the same
set of γ-FLAG variants. Extracts from transfected cells and unstransfected controls (-) were
subjected to immunoprecipitation with anti-myc antibody and assayed for AMPK activity. In
(C), the experiment used the γ1-FLAG constructs as in (B), except that the cells were incubated
with or without 10 mM deoxyglucose for 30 min prior to lysis, and the complexes were
immunoprecipitated with anti-FLAG antibody.
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Fig. 6.
(A) Co-precipitation of β1 and β2 with γ-FLAG variants in HeLa cells; (B) co-precipitation of
α1 and α2 with γ-FLAG variants in HeLa cells; (C) co-precipitation of β1 with γ-FLAG variants
in wild type MEFs; (D) co-precipitation of β1 with γ-FLAG variants in α1/α2 double knockout
MEFs. In (A), plasmids encoding β1 or β2 were co-expressed in HeLa cells with γ-FLAG
fusions with γ1 or γ3 that either contained contained (γ1L, γ3L) or did not contain (γ1S, γ3S)
the pre-CBS1 sequence. Cell lysates were immunoprecipitated with anti-FLAG antibody and
lysates (L) and immunoprecipitates (IP) from transfected cells were analyzed by Western
blotting using anti-pan β antibodies. In (B), plasmids encoding myc-α1 and myc-α2 were co-
expressed in HeLa cells with the same γ-FLAG variants as in (A). Cell lysates were
immunoprecipitated with anti-FLAG antibody and lysates (L) and immunoprecipitates (IP)
from transfected cells and untransfected controls were analyzed by Western blotting using anti-
myc (to detect α subunits) and anti-FLAG (to detect γ subunits). In (C), plasmids encoding
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myc-α1 and/or β1 were co-expressed in WT MEFs with γ1-FLAG fusions that either contained
(γ1L) or did not contain (γ1S) the pre-CBS1 sequence. Cell lysates were immunoprecipitated
with anti-FLAG antibody and lysates (L) and immunoprecipitates (IP) from transfected cells
and untransfected controls were analyzed by Western blotting using a mixture of anti-α1 and
anti-α2 antibodies or anti-pan-β antibodies. (D) was the same as (C) except that double
knockout MEFs were used.
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Fig. 7.
The second Bateman domain in γ1 is required to interact with α2 and β2. Yeast CTY10.5d
strain was transformed with plasmids expressing LexA-AMPKα2 or LexA-AMPKβ2 and C-
terminal truncated forms of GAD-AMPKγ1. Transformants growing exponentially in SC-4%
glucose medium were harvested and the β-galactosidase activity measured. Values correspond
to means from four to six different transformants (standard deviation lower than 15% in all
cases; not shown). Crude extracts from these transformants were analysed by western blot
using anti-HA polyclonal antibodies (plasmid pACT2 generated GAD-HA fusion proteins).
One representative transformant from each interaction is shown.
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Table I
Oligonucleotides used in this study. New restriction sites are underlined.
Name Sequence
Gamma3-SalI 5'-GCAGGTCGACTCAGGCCCCGAGGGCATCGATGC-3'
Gamma3-A 5'-CGATGAATTCAGCAGCTCATGGCCATCACCAGC-3'
Gamma3-B 5'-CGATGAATTCCGGTCCAGGCCAGCTGCTGAG-3'
Gamma3-C 5'-CGATGAATTCTCTGACTGTACAGCCTCAGCTGC-3'
Gamma3-D 5'-CGATGAATTCGAAGAGAGGCCTGCCCTGTGC-3'
Gamma3-E 5'-CGATGAATTCTCCAAGCTAGTCATCTTCGAC-3'
Gamma3-F 5'-CGATGAATTCAAGCCTCTGGTCTCCATCTCTCC-3'
Gamma1-1 5'-GAGGGCGGCCGCCAATGGAGTCGGTTGCTGCAG
Gamma1-2 5'-GGGCTCGAGTTACAGCAGGCAGGCAGTGAG-3'
Gamma1-CBS1 5'-CGGCCCCGGGCTCCAAGCTGGTGGTATTTGATAC-3'
Gamma1-CBS123 5'-GCGCTCGAGTCACACAGACACATCTAGGTTGTTG-3'
Gamma2-CBS1 5'- CGGCCCCGGGTTCAAAGCTTGTTGTCTTTGATAC-3'
Gamma2-2 5'- GCGTCTCGAGTCACTCCGTTTCTGTCTCCTTTTG-3'
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